Ascentage Pharma GR-ADRAAPG
13F holders, Q2 2026 (June 30)8holders +1
3new positions
2sold out
1famous investor
$17.55avg. 13F price*
At the end of Q2 2026, 8 institutions reported holding Ascentage Pharma GR-ADR (AAPG) in their 13F filings, up 1 from Q1 2026. 3 opened new positions and 2 sold out. The largest holders were Point72 Asset Management ($243K), Morgan Stanley ($16K) and Wells Fargo & Company ($4K). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Ascentage Pharma GR-ADR
- CUSIP
- 04390B105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $4K |
| Exits | 2 | $323K |
All 13F filers, Q1 2026 → Q2 2026: 628 shares bought and 15,856 shares sold, net −15,228 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Point72 Asset Management | 0.00% | Reduce -13.8% | 13,841 | $243K |
| Morgan Stanley | 0.00% | Add +84.5% | 919 | $16K |
| Wells Fargo & Company | 0.00% | New | 200 | $4K |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 24 | $421 |
| UBS Group AG | 0.00% | Reduce -87.9% | 15 | $263 |
| BlackRock, Inc. | 0.00% | New | 6 | $105 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $18 |
| Royal Bank of Canada | 0.00% | No change | 6 | $0 |
"% of holder's portfolio" is AAPG's weight in each manager's 13F, not the share of Ascentage Pharma GR-ADR the manager owns.